[86] described that RG7834, a novel oral HBV gene expression inhibitor, could decrease the amounts of viral proteins and reduce viremia. RG7834 is a little-molecule compound belonging into the dihydroquinolizinones chemical class comparable to RNAi but as a result of a distinct mechanism.Additionally, a mix of antiviral medications using an immune-… Read More